There are new therapies showing dramatic results for treatment-resistant depression (TRD), post-traumatic stress disorder (PTSD) and other mental health issues. These therapies involve the use of psychedelics (psilocybin and MDMA). These psychedelic-assisted therapies are undergoing Phase 3 FDA and European Medical Association (EMA) trials and the FDA has designated them as Breakthrough Therapies. Studies have shown that just one therapist-led session has cured otherwise ‘incurable’ traumas and other mental health issues.
Many of our beliefs about psychedelics are based on misinformation originating in the 1960’s. These medicines have the potential to revolutionize mental health care. I am working to help shift public perspective and reduce stigmatization related to these medicines and am involved with organizations that support researchers studying psychedelic treatments for a wide range of mental health indications, as well as investigating their possible use in conflict resolution.
For more information about these therapies: